Linda,
You are right:Avastin is not yet approved for metastatic BC since Genentech
application for approval by the FDA is on hold until the manufacturer supplies more info on safety & efficacy based on the results of the clinical trials.
This may delay approval by about 12 months as commented in this press release:
http://www.gene.com/gene/news/press-...etail&id=10007
Monday, Sep 11, 2006
Genentech Receives Complete Response Letter From FDA for Avastin in Metastatic Breast Cancer
Your onc may nevertherless be willing to prescribe Avastin off label if he feels the clinical trials showed good outcomes.
Threaded Mode